- Open Access
Impaired immune responses in the lungs of aged mice following influenza infection
© Toapanta and Ross. 2009
- Received: 19 April 2009
- Accepted: 18 November 2009
- Published: 18 November 2009
Each year, influenza virus infection causes severe morbidity and mortality, particularly in the most susceptible groups including children, the elderly (>65 years-old) and people with chronic respiratory diseases. Among the several factors that contribute to the increased susceptibility in elderly populations are the higher prevalence of chronic diseases (e.g. diabetes) and the senescence of the immune system.
In this study, aged and adult mice were infected with sublethal doses of influenza virus (A/Puerto Rico/8/1934). Differences in weight loss, morbidity, virus titer and the kinetics of lung infiltration with cells of the innate and adaptive immune responses were analyzed. Additionally, the main cytokines and chemokines produced by these cells were also assayed.
Compared to adult mice, aged mice had higher morbidity, lost weight more rapidly, and recovered more slowly from infection. There was a delay in the accumulation of granulocytic cells and conventional dendritic cells (cDCs), but not macrophages in the lungs of aged mice compared to adult animals. The delayed infiltration kinetics of APCs in aged animals correlated with alteration in their activation (CD40 expression), which also correlated with a delayed detection of cytokines and chemokines in lung homogenates. This was associated with retarded lung infiltration by natural killer (NK), CD4+ and CD8+ T-cells. Furthermore, the percentage of activated (CD69+) influenza-specific and IL-2 producer CD8+ T-cells was higher in adult mice compared to aged ones. Additionally, activation (CD69+) of adult B-cells was earlier and correlated with a quicker development of neutralizing antibodies in adult animals.
Overall, alterations in APC priming and activation lead to delayed production of cytokines and chemokines in the lungs that ultimately affected the infiltration of immune cells following influenza infection. This resulted in delayed activation of the adaptive immune response and subsequent delay in clearance of virus and prolonged illness in aged animals. Since the elderly are the fastest growing segment of the population in developed countries, a better understanding of the changes that occur in the immune system during the aging process is a priority for the development of new vaccines and adjuvants to improve the immune responses in this population.
- Natural Killer Cell
- Influenza Virus
- Adult Mouse
- Aged Mouse
Influenza virus infects a variety of species, including swine, horses, birds, and humans. Hemagglutinin (HA) and neuraminidase (NA) are the important antigenic proteins on the surface of the virus and both undergo two types of antigenic variation: drift and shift. Antigenic drift involves minor changes in these antigens, while shift involves major changes in these molecules that result from replacement of a gene segment(s). New viral variants, due to antigenic drift, emerge constantly and are responsible for yearly epidemics. In contrast, antigenic shifts can produce new virus strains to which most people have no immunity resulting in pandemics. On average, influenza virus infects 5-10% of the global population and results in approximately 500,000 deaths annually. In the United States, influenza virus infections account for 200,000 cases of hospitalizations and 36,000 deaths [1, 2]. Among the most susceptible populations are children, pregnant women, the elderly (>65 years) and people with chronic respiratory diseases.
The fastest growing segment of the United States population is individuals over 65 years of age. The elderly have an increased morbidity and mortality to due influenza, as a result of secondary bacterial and viral infections . Several immunological changes occur in the senescent immune system in humans, including impairments in initiation and activation of the immune response and induction and maintenance of immune memory [4, 5]. In the case of influenza infections, even though the hospitalization rates for children less than 5 years and adults over 70 years of age are almost identical, individuals older than 70 years have a 35-fold increase in mortality [6, 7]. Vaccination can reduce the rates of hospitalization, however protection induced by immunizations is diminished in the elderly compared to the adults as demonstrated by lower antibody titers and higher rates of respiratory illness . Additionally, cell-mediated immune responses to vaccinations are decreased in the elderly [9, 10].
Studies with sub-lethal virus infections in aged mice have closely resembled the human situation indicating a delay in virus clearance. This delay was accompanied by a delay and decrease in T-cell responses [4, 5, 11, 12]. Importantly, age-associated changes in the innate response to virus infection, such as production of interferons (IFN) alpha and beta and the activation of innate cells (macrophages, DCs, granulocytes and NK cells), has been poorly explored.
The study presented in this report, globally evaluated the kinetics of activation and infiltration of the primary innate and adaptive immune cell populations in aged and adult mice following influenza virus infection. There were alterations in APCs in aged animals including the up-regulation of activation markers, especially CD40, which correlated with delayed production of IL-12 and several other cytokines including IFN-γ and IL-6 in the lungs of aged animals. Chemokine production was also altered, which also correlated with a delayed infiltration of innate cells and lymphocytes into lungs. Of these populations, the activation of NK and B-cells was altered and the production of neutralizing anti-influenza antibodies was detected 2 days later in aged mice compared to adult mice. Aged mice also had a significantly lower percentage of activated influenza HA-specific CD8+ T-cells. The alterations in the immune response correlated with a delay in virus clearance and slower recovery in aged animals. In summary, all these findings suggest that early alterations in the innate immune system translate into delayed activation of the adaptive immune responses and consequently in prolonged illness. As the elderly population continues to increase, a better understanding of the changes that the immune system undergoes with the aging process is becoming a key factor for the development of new vaccines and adjuvants to improve the immune responses in this segment of the population.
Virus infections and Animals
Tissue harvesting and cell isolation
Lungs were harvested (n = 3 - 6 per time point per experiment) on days 0, 1, 2, 3, 5, 7, 9, 11, 15 and 19 post-infection. In some specific time points, a higher number of animals were used to confirm results for some assays (see legend on each figure for description on time points with higher number of animals). Lungs were exposed by opening the chest cavity and rinsed with cold 1× PBS (4 ml), through the right heart ventricle. The lungs were then removed and forced into suspension in 1× PBS (4 ml) using a cell strainer (70 μm) and a syringe plunger. Tissue samples were then spun down (2500 rpm, 5 min, 4°C) and the supernatants of the lung homogenates collected and stored at -80°C until analysis. The remaining cell pellet was resuspended in 5 ml of red blood cell lysis buffer (ACK buffer) and incubated for 5 min at room temperature (RT). Cells were then washed (2× - 2500 rpm, 5 min, 4°C) with 15 ml of 1× PBS and resuspended in 1 ml 10% RPMI (Mediatech, Manassas, VA, USA). Total number of viable cells was determined by trypan blue exclusion.
Lung virus titers were determined by plaque assay using Madin Darby canine kindey (MDCK) cells (ATCC, Manassas, VA, USA). Briefly, MDCK cells were grown in 6 well plates until 90% of the cell monolayer was confluent. Cells were washed twice in DMEM (Mediatech, Manassas, VA, USA). Lung supernatants were gently thawed on ice and 100 μl of the different dilutions (101 to 106) were plated on MDCK cells and allowed to adsorb for 1 hour at RT. Excess virus was washed away with DMEM (2×) and cells were overlayed with a 2.5 ml of 1:1 mixture of 1.6% agarose, 2× L-15 medium (Cambrex, East Rutherford, NJ, USA) and 0.6 μg/ml trypsin (Sigma, St. Louis, MO, USA). Plates were incubated for 48 hours (37 C, 5% CO2) and then the agarose removed, cells fixed (70% ethanol) and stained with 1% crystal violet. Virus plaques were counted and the plaque forming units per ml (pfu/ml) were determined using the formula: (# plaques × dilution factor)/0.1 ml. All samples were run in duplicate.
Multiplex and ELISA for detection of cytokines
Lung homogenate supernatants were assayed for a panel of cytokines and chemokines (IL-1 α, IL-1β, IFN-γ, TNF-α, IL-12 (p70), IL-6, KC, MIP-1β, RANTES and MCP-1) using a multiplex-assay (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. Briefly, 50 μl of a 1× anti-cytokine bead dilution were added to activate 96-well filter plates (100 μl of Bio-Plex Assay Buffer A) and then the plates were washed (2× - 100 μl of Bio-Plex Wash Buffer A). Lung cell suspensions were gently thawed, centrifuged (1 min at 12,000 rpm) and added to the appropriate wells (50 μl). The plates were then incubated with shaking (300 rpm) in the dark for 30 min at 25°C, followed by washes (3×) and addition of the detection antibodies (25 μl/well). Plates were incubated in the dark (30 min, shaking at 300 rpm), followed by three washes, and then 50 μl of a 1:100 dilution of Streptavidin-phycerythrin (PE) was added. Following the 10 min incubation, the plates were washed (3×) and then the beads in each well were resuspended in 125 μl of Bio-Plex Assay Buffer A. The plates were shaken for 30 sec (1,100 rpm) and immediately read using a Luminex® 200™ Total System machine (Luminex Corp, Austin, TX, USA). A total of 100 beads per region in a sample volume of 50 μl were counted. The data were analyzed using the LDS1.7 Software. All samples were assayed in duplicate.
Additional cytokines (IFN-α, IFN-β and TGF-α) were assayed by sandwich ELISA (PBL Biomedical Laboratories, Piscataway, NJ and eBioscience, San Diego, CA, USA). Briefly, 100 μl of lung homogenate supernatants were added to anti-cytokine coated plates and incubated at RT for 1 hr. Plates were washed (200 μl) with the appropriate wash buffer, followed by the addition of the appropriate detecting anti-cytokine biotinylated antibody (100 μl). Plates were incubated for 24 hr (IFN-α) or 1 hr (IFN-β and TGF-α) at RT. Following 3 washes with the appropriate buffers, avidin-HRP reagent (100 μl) were added and the plates were incubated for 1 hr at RT. Finally, 100 μl of TMB substrate was added to each well and the plates were incubated in the dark for 20-30 min. The reaction was stopped with 50 μl sulfuric acid (2N) and the colorimetric analysis was determined by a spectrophotometer at an optical density of 450. Cytokine concentrations were determined by linear regressions using the standard curve provided in the kit as reference. Each sample was assayed at least in duplicate.
Isolated lung cells (1-2 × 106) were stained for flow cytometry (FACS) analysis. Briefly, cells were resuspended (1 × 107/ml) in FACS buffer (1× PBS, 3% FBS, 1% Sodium Azide, 1 mM EDTA). Cells (100 μl) were plated in v-shaped 96-well plates and gently centrifuged (1200 rpm, 3 min, 4°C) to pellet. Supernatants were removed and then cells were blocked with mouse anti-Fc antibody (BD Pharmigen, San Jose, CA) for 20 min. Cells were stained with the appropriate antibody panels specific for cell surface markers conjugated to specific flurochromes, CD19-APC-Cy7, CD69-PE-Cy7, CD8-FITC, CD11b-PE, and CD11c-PE-Cy7, (BD Pharmigen, San Jose, CA, USA) or CD3-APC-Cy7, CD4-APC, CD69-PE, CD49b-Pe-Cy7, CD40-APC, MCH Class II-Alexa Fluor 700, F4/80-APC and Ly-6G-FITC (eBioscience, San Diego, CA, USA), as well as their isotype controls. Cells were then washed (2×) with 200 μl of FACS buffer and stained for viability (Live/Dead fixable blue-fluorescent reactive dye, Molecular probes, Eugene, OR, USA) for 30 min. Samples were washed PBS (2×) and then FACS buffer (1×). Finally, cells were fixed with 1% formalin and stored at 4°C. Samples were collected in a BD LSR II flow cytometer and the data were analyzed by FlowJo software (Tree Start Inc. Ashland, OR, USA).
Influenza specific CD8+ cells were assayed using HA518-526 (IYSTVASSL) and NP147-155 (TYQRTRALV) MHC class I (H-2Kd) restricted immunodominant peptides sequences conjugated to Pentamers-PE (ProImmune, Oxford, UK).
For intracellular staining 2 × 106 cells were plated and stimulated with HA (IYSTVASSL) and NP (TYQRTRALV) MHC class I (H-2Kd) restricted peptides (1 ug/ml) (Pepscan, Lelystad, The Netherlands) for 5 hours (37 C, 5% CO2) in media containing Monensin (eBioscience, San Diego, CA, USA) and Brefeldin A (Sigma, St Louis, MO, USA). Following stimulation, the cells were surface stained as described before and then permeabilized and stained with intracellular antibodies: IFN-gamma-PE-Cy7 (BD Pharmigen, San Jose, CA, USA), TNF-alpha-FITC (eBioscience, San Diego, CA, USA) and IL-2-PE (eBioscience, San Diego, CA, USA).
MPO was assayed by ELISA (HyCult, Uden, The Netherlands) in lung supernatants of infected mice (three per time point). Harvested lungs were harvested and forced into suspension in 3 ml of lysis buffer (200 mM NaCl, 5 mM EDTA, 10 mM tris, 10% glycine, 1 mM PMSF), 1 ug/ml leupeptide and 28 ug/ml aprotinine, at pH 7.4). A 1:16 dilution in 1× PBS was assayed following the suggestion of the manufacturer.
Hemagglutination inhibition (HAI) Assay
HAI assay was used to assess functional antibodies to the HA able to inhibit agglutination of turkey red blood cells (TRBC). This assay was performed as described previously . Briefly, one part sera were treated with three parts of receptor destroying enzyme (RDE) (37°C - overnight). RDE was later inactivated by incubation at 56°C (30 min) and six parts of PBS added. RDE-treated sera were two-fold serially diluted in v-bottom microtiter plates. An equal volume of PR8 virus, adjusted to approximately 8 HAU/50 ml, was added to each well. The plates were covered and incubated at room temperature for 20 min followed by the addition of 1% TRBC (Lampire Biologicals, Pipersville, PA, USA) in PBS. The plates were mixed by agitation, covered, and the RBCs were allowed to settle for 30 min at room temperature. The HAI titer was determined by the reciprocal dilution of the last well which contained non-agglutinated RBC. Positive and negative serum controls were included for each plate.
Differences in weight loss, sickness score, virus titer, cytokine/chemokines and flow cytometry data between mice of the same age group were analyzed by one-way ANOVA, followed by Dunnett's post test. Analysis of results from aged and adult mice at different time points (multiparametric) was assessed by two-way ANOVA tests. Significant was identified as p < 0.05, the data were further analyzed by a Bonferroni post-test. Significant differences in survival were measured using log-rank and Wilcoxon-Gehan tests. Statistical analyses were done using GraphPad software.
Enhanced morbidity in aged mice following infection with influenza virus
Enhanced number of innate cells in the lungs of influenza infected mice
Adaptive Immune Cell Markers
Activated B Cells
CD4+ T Cells
Activated CD4+ T Cells
CD8+ T Cells
Activated CD8+ T Cells
Activation markers of innate cells
Cytokines and chemokines produced by macrophages and cDCs
The concentrations of IFN-γ and IL-6, both highly produced by lymphocytes, began increasing in the lungs of adult mice at day 5 post-infection and 2-3 days later in aged mice. Despite of the earlier increase of IFN-γ in adult animals, the peak of this cytokine was higher in aged animal (day 7 p < 0.01) (Fig. 5E). On the other hand, the peak of IL-6 was similar in both ages of mice (Fig. 5F). There were no differences in the levels of IFN-α and IFN-β cytokines measured in the supernatants of lung homogenates between adult and aged mice (data not shown).
Lymphocytic immune cell phenotypes following infection
Influenza specific T-cell responses
Influenza virus affects all ages of humans; however, the elderly (>65 years-old) have increased susceptibility to infections and are especially predisposed to complications . The increased morbidity and mortality reported in elderly populations are due to several factors that include subjacent chronic diseases, such as diabetes and cancer, as well as dysfunctions in the senescent immune system. The mouse model has proven to be an important tool to explore the pathogenesis of influenza, especially due to the similarities to human infections . The elderly mouse model has also proven to be useful to explore the effects of age on the immune responses to several respiratory infectious agents including Mycobacterium tuberculosis and influenza virus [18, 28, 29]. However, most of the studies have focused on the T-cell compartment and indicated that altered T-cell proliferation and memory results in decreased and delayed CTL activity [4, 28, 30–33]. Few reports have addressed the role of the aging innate immune system on the protection to influenza virus and only few reports have explored phagocytic functions, NK cell activity, and IFN-α/β production in the aged animals using other pathogens [34–40]. In this study, the immune responses to influenza virus in the lungs of aged animals were evaluated. Alterations in APC up-regulation of CD40 correlated with delayed production of cytokines and chemokines in the lungs, which correlated with infiltration of immune cells into these organs. Finally, this correlated with a delayed activation of the adaptive immune responses and subsequent delay in clearance of virus.
The earlier weight loss and enhanced morbidity in aged animals suggests less effective innate immune responses against influenza virus in these mice. Among the cells of the innate immune system, granulocytes, DCs and macrophages are critical players, since these are the first cells to encounter a pathogenic microorganism. Among granulocytes, neutrophils are the predominant population (>90%) and the role of these cells in influenza infection has recently been elucidated [39, 41]. One mechanism of granulocyte activity is the release of lytic proteins, such as myeloperoxidase, from endocytic granules. Aged animals had delayed lung infiltration kinetics following influenza infection (Fig. 3B); however, similar levels of MPO were produced by adult and aged mice, except for day 9, where higher levels were detected in the aged group (p < 0.05) (data not shown). This indicates that for the main part, the neutrophil function was not altered in aged animals infected with influenza virus. The higher MPO levels at day 9 might contribute to the enhanced sickness score detected in aged animals at this time point. The data also suggest that the difference in infiltration kinetics may be associated with impaired chemotaxis. Consistent with this hypothesis, the secretion of the chemokine, KC (neutrophil chemoattractant), was delayed in aged mice following influenza virus infection (Fig. 9B).
Interestingly, the major differences in granulocyte infiltration kinetics were detected between days 11-19 (Fig. 3B), which corresponds with the resolution phase of the disease. The higher granulocyte infiltration in aged animals also correlated with a prolonged presence of macrophages (Fig. 3C) and was associated with a higher sickness score and prolonged disease. A prolonged infiltration of the lungs with cells from the inflammatory phase might account for the prolonged disease stage in the animals. To further support this, MPO was higher at day 9 in aged animals and reports that aged populations have a higher tendency to produce inflammatory cytokines, such as TNF-α and IL-α, during infections have been published and correlates with our data (Fig. 5C) [21, 22]. In summary, all these immune markers suggest that the immune system can be contributing to the enhanced sickness score detected in the aged group of animals.
APCs are among the first leukocytes to recognize infectious microorganisms. DCs are especially responsible of the surveillance in different tissues and subsequent migration to the lymph nodes where they interact with T-cells to present antigens and trigger the adaptive immune response. In the murine lung, different DC populations have been recently described, one of the predominant populations includes resident CD11bhigh/CD11chigh cells, also known as conventional DCs (cDCs) (reviewed in ). The other APC populations analyzed in these animals represent lung macrophages (CD11bhigh/CD11clow/Gr1high). It is important to note that lung (interstitial) macrophages are different from alveolar macrophages. The later cells suppress the functional characteristics of lung DCs . Alveolar macrophages in addition to CD11c, express F4/80 . Both APC populations analyzed in our experiments have low F4/80 expression (data not shown), providing evidence that the analyzed cells were not alveolar macrophages. Upon encountering the antigen, APCs up-regulate several molecules, such as MHC class II and CD40 in order to present antigens to CD4+ T-cells and provide the required second signal to fully activate these cells . MHC class II up-regulation was not altered neither in lung macrophages nor cDCs from aged mice following influenza infection. However, CD40 up-regulation was delayed in both lung macrophages and cDCs cells, suggesting differences in complete priming of the APCs in aged mice. Fully primed APCs produce cytokines and chemokines that will attract cells to the lungs and subsequently activate them during influenza virus infection [44, 45]. CD40 interaction with CD40L, is important to fully activate APCs [46, 47] and the role of CD40 in stimulating the production of IL-12 is well documented (reviewed in [43, 48]) The concentration of IL-12p70, the active form of IL-12, was not only significantly higher in the lungs of adult mice, but also spiked earlier compared to aged mice following influenza infection (Fig. 7A). Considering the importance of CD40 in the induction of IL-12, the delayed CD40 up-regulation in aged animals, most likely contributed to a retarded IL-12p70 production and reduced activation of aged APCs.
In addition to IL-12, activated APCs can produce other pro-inflammatory cytokines, such as IL-1β, IL-1α, and TNF-α (Fig. 5) [19, 20, 49]. Interestingly, not all of these cytokines showed higher concentrations in adult mice compared to aged mice following influenza infection; however, in all cases the peak of cytokine level occurred earlier in adult animals. The higher peak of the pro-inflammatory cytokines detected in elderly animals correlate with reports indicating that elderly populations have enhanced basal levels of these cytokines (e.g. TNF-α) and tendency to produce higher levels upon infection [21, 22, 50]. Similar to cytokines, the peaks of chemokine production by APCs (MIP-1β, MCP-1, RANTES and KC) to influenza infection were delayed in aged mice. This correlated with the delayed CD40 up-regulation in aged animals, which further suggests a delay in full activation of APCs.
IL-12p70 produced by activated APCs stimulates NK cells and CD4+ T-cells to produce IFN-γ [48, 51, 52]. Consistent with the delayed production of IL-12p70 in the lungs of aged animals to influenza infection, IFN-γ spiked two days later (day 7 vs. day 5) in aged mice compared to adults (Fig. 5E). Consistent with the delayed production of the chemokines, NK cells, CD4+ and CD8+ T-cells showed delayed infiltration into the lungs of aged animals (Figs. 7B, 9A and 9B). Furthermore, the up-regulation of the early activation marker CD69 was delayed on NK cells in aged mice (Fig. 7D). Previous reports had shown no alterations of NK cells with age in humans and only small changes in mice [53–57]. However, our data coincides with a recent report that demonstrates alterations in the NK compartment of aged animals infected with influenza virus .
B-cells showed similar patterns of infiltration between aged and adult mice following influenza infection (Fig. 7C). The kinetics of this population were delayed compared to CD4+ and CD8+ T-cells (Fig. 9), since B-cells started to infiltrate the lungs between days 9 and 11, upon which these cells significantly increased in adult and aged animals (Fig. 8D). Despite this, surface expression of CD69 was detected by day 3 in adults and day 5 in aged mice (Fig. 7E), which coincided with an earlier detection of anti-influenza neutralizing antibodies in adult mice compared to aged mice (Fig. 8). Interestingly, CD69 up-regulation by CD4+ T-cells was similar between adult and aged mice (Fig. 9C and 9D), suggesting that the differences in IFN-γ production detected between days 3 to 9 between aged and adult mice is primarily due to secretion of this cytokine by NK cells.
Virus titration in the lungs of aged animals showed a delayed virus clearance. However, the data also demonstrated that despite a similar onset of virus between adult and aged animals, the peak was lower in the later set of animals. This might be the result of a reduced homeostasis of epithelial cells of aged animals. Aging reduces the division potential of cells (replicative senescence) both in vivo and in vitro. Some of these changes have been only partially explored in the lungs; however, affect most organs in the models used [64–67]. A reduced replication capability can be translated in reduced virus production by aged animals during peak days. Even with lower virus titer in the lungs of aged animals, the alterations in the immune responses (innate and adaptive) might account for reduced virus clearance and the enhanced tendency to produce inflammatory cytokines (e.g. TNF-α) [21, 22] by these animals might be responsible for the enhanced sickness score.
The data in this study shows that age affects the global immune responses to influenza infection. Alterations in CD40 up-regulation by aged cDCs and lung macrophages suggested impairments in their activation. Remarkably, this correlated with altered levels of cytokines (especially IL-12p70) and chemokines, which also correlated with delayed NK and T-cell infiltration. Furthermore, influenza (HA)-specific T-cells were reduced in aged animals. These findings correlated with several reports demonstrating that age affects APC Toll-like receptors expression and function, antigen presentation (defect in exogenous pathway) and CD8+ stimulating capacity [50, 68–71]. Some studies, on the other hand, have not reported defects in DC function in the elderly . This might indicate that different populations of APCs at different tissues are affected differently by age. Also, this may be the result of genetic differences between mouse strains. Our data also demonstrated altered humoral immune responses (B-cell activation and HAI titers). Therefore, the alterations in the APCs are most likely just one step in a large chain of alterations present in the aging immune system. The final outcome of delayed virus clearance and slow recovery is probably the addition of various factors and not only involve dysfunction in antigen presentation.
The current study provides an overview of the global effects that aging has on the immune system following influenza infections and demonstrates that alterations are found in the innate, as well as acquired immune compartment. Remarkably, alterations in lung APCs seem to trigger a cascade of events that affected the acquired immune responses. According to the US Census Bureau , during 20th century, the rate of growth of the elderly population has greatly exceeded the growth rate of the US population as a whole. The elderly increased by a factor of 11, from 3 million in 1900 to 33 million in 1994, while the total population and the population younger than 65 years of age tripled. It is expected that by 2030 the elderly population will double. Considering the significant increase in the elderly population and increased susceptibility to certain infectious agents, it is becoming imperative to determine the effects of age on the immune system. Identifying the main groups of cell(s) affected by the aging process may help to further explore the mechanisms behind the immune alterations and design better vaccines and adjuvants to boost the immune responses in this important group of the population.
The authors would like to thank Drs. Russell Salter and Rick A. Bright for critical discussion and to Dilhari De Almeida and Matthew Dunn for technical assistance. This research was funded by the National Institutes of Health awards N01-AI50018 and R01-GM083602-01 to TMR.
- Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al.: The global circulation of seasonal influenza A (H3N2) viruses. Science 2008,320(5874):340–6.View ArticlePubMedGoogle Scholar
- Stohr K: Influenza-WHO cares. Lancet Infect Dis 2002,2(9):517.View ArticlePubMedGoogle Scholar
- Yoshikawa TT: Important infections in elderly persons. West J Med 1981,135(6):441–5.PubMedPubMed CentralGoogle Scholar
- Bender BS, Johnson MP, Small PA: Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology 1991,72(4):514–9.PubMedPubMed CentralGoogle Scholar
- Bender BS, Taylor SF, Zander DS, Cottey R: Pulmonary immune response of young and aged mice after influenza challenge. J Lab Clin Med 1995,126(2):169–77.PubMedGoogle Scholar
- Couch RB, Kasel JA, Glezen WP, Cate TR, Six HR, Taber LH, et al.: Influenza: its control in persons and populations. J Infect Dis 1986,153(3):431–40.View ArticlePubMedGoogle Scholar
- Webster RG: Immunity to influenza in the elderly. Vaccine 2000,18(16):1686–9.View ArticlePubMedGoogle Scholar
- Powers DC, Sears SD, Murphy BR, Thumar B, Clements ML: Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. J Clin Microbiol 1989,27(12):2666–71.PubMedPubMed CentralGoogle Scholar
- Powers DC, Belshe RB: Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993,167(3):584–92.View ArticlePubMedGoogle Scholar
- Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA: Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007,7(10):658–66.View ArticlePubMedGoogle Scholar
- Murasko DM, Jiang J: Response of aged mice to primary virus infections. Immunol Rev 2005, 205:285–96.View ArticlePubMedGoogle Scholar
- Dong L, Mori I, Hossain MJ, Kimura Y: The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis 2000,182(2):391–6.View ArticlePubMedGoogle Scholar
- Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, et al.: Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008,3(1):e1501.View ArticlePubMedPubMed CentralGoogle Scholar
- Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM: Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 2003,171(6):3128–35.View ArticlePubMedGoogle Scholar
- Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, et al.: The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 2002,169(7):3876–82.View ArticlePubMedGoogle Scholar
- Pecora ND, Fulton SA, Reba SM, Drage MG, Simmons DP, Urankar-Nagy NJ, et al.: Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cellular immunology 2008,254(2):94–104.View ArticlePubMedPubMed CentralGoogle Scholar
- GeurtsvanKessel CH, Lambrecht BN: Division of labor between dendritic cell subsets of the lung. Mucosal Immunol 2008,1(6):442–50.View ArticlePubMedGoogle Scholar
- Han SN, Meydani SN: Antioxidants, cytokines, and influenza infection in aged mice and elderly humans. J Infect Dis 2000, 1:S74–80.View ArticleGoogle Scholar
- Hennet T, Ziltener HJ, Frei K, Peterhans E: A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992,149(3):932–9.PubMedGoogle Scholar
- Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ: Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 1995,268(1 Pt 2):R78–84.PubMedGoogle Scholar
- Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al.: Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004,52(7):1105–13.View ArticlePubMedGoogle Scholar
- Trzonkowski P, Mysliwska J, Godlewska B, Szmit E, Lukaszuk K, Wieckiewicz J, et al.: Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav Immun 2004,18(2):135–48.View ArticlePubMedGoogle Scholar
- Bozic CR, Kolakowski LF Jr, Gerard NP, Garcia-Rodriguez C, von Uexkull-Guldenband C, Conklyn MJ, et al.: Expression and biologic characterization of the murine chemokine KC. J Immunol 1995,154(11):6048–57.PubMedGoogle Scholar
- Haelens A, Wuyts A, Proost P, Struyf S, Opdenakker G, van Damme J: Leukocyte migration and activation by murine chemokines. Immunobiology 1996,195(4–5):499–521.View ArticlePubMedGoogle Scholar
- Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP: RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992,149(2):636–42.PubMedGoogle Scholar
- Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990,347(6294):669–71.View ArticlePubMedGoogle Scholar
- Ward AC: Virulence of influenza A virus for mouse lung. Virus Genes 1997,14(3):187–94.View ArticlePubMedGoogle Scholar
- Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM: Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev 2002,123(8):1167–81.View ArticlePubMedGoogle Scholar
- Vesosky B, Turner J: The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol Rev 2005, 205:229–43.View ArticlePubMedGoogle Scholar
- Effros RB, Walford RL: The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin. Cell Immunol 1983,81(2):298–305.View ArticlePubMedGoogle Scholar
- Effros RB, Walford RL: Diminished T-cell response to influenza virus in aged mice. Immunology 1983,49(2):387–92.PubMedPubMed CentralGoogle Scholar
- Jiang J, Gross D, Elbaum P, Murasko DM: Aging affects initiation and continuation of T cell proliferation. Mech Ageing Dev 2007,128(4):332–9.View ArticlePubMedGoogle Scholar
- Kapasi ZF, Murali-Krishna K, McRae ML, Ahmed R: Defective generation but normal maintenance of memory T cells in old mice. Eur J Immunol 2002,32(6):1567–73.View ArticlePubMedGoogle Scholar
- Herrero C, Marques L, Lloberas J, Celada A: IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J Clin Invest 2001,107(4):485–93.View ArticlePubMedPubMed CentralGoogle Scholar
- Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S: Innate immunity in aging: impact on macrophage function. Aging Cell 2004,3(4):161–7.View ArticlePubMedGoogle Scholar
- Rytel MW: Effect of age on viral infections: possible role of interferon. J Am Geriatr Soc 1987,35(12):1092–9.View ArticlePubMedGoogle Scholar
- Solana R, Pawelec G, Tarazona R: Aging and innate immunity. Immunity 2006,24(5):491–4.View ArticlePubMedGoogle Scholar
- Watanabe Y, Hashimoto Y, Shiratsuchi A, Takizawa T, Nakanishi Y: Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun 2005,337(3):881–6.View ArticlePubMedGoogle Scholar
- Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y: Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 2007,178(4):2448–57.View ArticlePubMedGoogle Scholar
- Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM: Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 2008,129(4):223–30.View ArticlePubMedGoogle Scholar
- Tate MD, Brooks AG, Reading PC: The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res 2008, 9:57.View ArticlePubMedPubMed CentralGoogle Scholar
- Franke-Ullmann G, Pfortner C, Walter P, Steinmuller C, Lohmann-Matthes ML, Kobzik L: Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. J Immunol 1996,157(7):3097–104.PubMedGoogle Scholar
- Grewal IS, Flavell RA: CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998, 16:111–35.View ArticlePubMedGoogle Scholar
- Oh S, Eichelberger MC: Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. J Virol 2000,74(17):7738–44.View ArticlePubMedPubMed CentralGoogle Scholar
- Oh S, McCaffery JM, Eichelberger MC: Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. J Virol 2000,74(12):5460–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Demangel C, Palendira U, Feng CG, Heath AW, Bean AG, Britton WJ: Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect Immun 2001,69(4):2456–61.View ArticlePubMedPubMed CentralGoogle Scholar
- Lazarevic V, Myers AJ, Scanga CA, Flynn JL: CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M.tuberculosis infection. Immunity 2003,19(6):823–35.View ArticlePubMedGoogle Scholar
- Zhang S, Wang Q: Factors determining the formation and release of bioactive IL-12: regulatory mechanisms for IL-12p70 synthesis and inhibition. Biochem Biophys Res Commun 2008,372(4):509–12.View ArticlePubMedGoogle Scholar
- Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002,10(2):417–26.View ArticlePubMedGoogle Scholar
- Paula C, Motta A, Schmitz C, Nunes CP, Souza AP, Bonorino C: Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design. Biogerontology 2009,10(1):13–25.View ArticlePubMedGoogle Scholar
- Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, et al.: Activation of NK cell cytotoxicity. Mol Immunol 2005,42(4):501–10.View ArticlePubMedGoogle Scholar
- Sartori A, Ma X, Gri G, Showe L, Benjamin D, Trinchieri G: Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells. Methods 1997,11(1):116–27.View ArticlePubMedGoogle Scholar
- Kutza J, Kaye D, Murasko DM: Basal natural killer cell activity of young versus elderly humans. J Gerontol A Biol Sci Med Sci 1995,50(3):B110–6.View ArticlePubMedGoogle Scholar
- Kiessling R, Klein E, Pross H, Wigzell H: "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975,5(2):117–21.View ArticlePubMedGoogle Scholar
- Kiessling R, Klein E, Wigzell H: "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975,5(2):112–7.View ArticlePubMedGoogle Scholar
- Plett A, Murasko DM: Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta. Mech Ageing Dev 2000,112(3):197–215.View ArticlePubMedGoogle Scholar
- Kutza J, Gross P, Kaye D, Murasko DM: Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diagn Lab Immunol 1996,3(1):105–8.PubMedPubMed CentralGoogle Scholar
- Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, et al.: Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 2001,166(3):1813–22.View ArticlePubMedGoogle Scholar
- Alsharifi M, Lobigs M, Regner M, Lee E, Koskinen A, Mullbacher A: Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. J Immunol 2005,175(7):4635–40.View ArticlePubMedGoogle Scholar
- Kohlmeier JE, Miller SC, Woodland DL: Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol 2007,178(8):4721–5.View ArticlePubMedGoogle Scholar
- Chen W, Anton LC, Bennink JR, Yewdell JW: Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 2000,12(1):83–93.View ArticlePubMedGoogle Scholar
- Chen W, Bennink JR, Morton PA, Yewdell JW: Mice deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus. J Virol 2002,76(20):10332–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, et al.: Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. J Immunol 2000,165(3):1182–90.View ArticlePubMedGoogle Scholar
- Rubin H: Cell aging in vivo and in vitro. Mech Ageing Dev 1997,98(1):1–35.View ArticlePubMedGoogle Scholar
- Ito K, Barnes PJ: COPD as a disease of accelerated lung aging. Chest 2009,135(1):173–80.View ArticlePubMedGoogle Scholar
- Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Woestijne KP: The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. Chest 1992,101(3):800–9.View ArticlePubMedGoogle Scholar
- Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Woestijne KP: The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. Chest 1992,101(3):793–9.View ArticlePubMedGoogle Scholar
- Plowden J, Renshaw-Hoelscher M, Gangappa S, Engleman C, Katz JM, Sambhara S: Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. Cell Immunol 2004,229(2):86–92.View ArticlePubMedGoogle Scholar
- Katz JM, Plowden J, Renshaw-Hoelscher M, Lu X, Tumpey TM, Sambhara S: Immunity to influenza: the challenges of protecting an aging population. Immunol Res 2004,29(1–3):113–24.View ArticlePubMedGoogle Scholar
- Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S: Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002,169(9):4697–701.View ArticlePubMedGoogle Scholar
- Linton PJ, Li SP, Zhang Y, Bautista B, Huynh Q, Trinh T: Intrinsic versus environmental influences on T-cell responses in aging. Immunol Rev 2005, 205:207–19.View ArticlePubMedGoogle Scholar
- Tesar BM, Walker WE, Unternaehrer J, Joshi NS, Chandele A, Haynes L, et al.: Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell 2006,5(6):473–86.View ArticlePubMedGoogle Scholar
- Hobbs F, Damon BL, Taeuber CM: Sixty-five plus in the United States. In Census UBot. US Government Printing Office; 1996:23–190.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.